drugset / Trial / NCT06003049
A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this clinical trial to determine the safety and effectiveness of treating the COPD symptoms with subcutaneous BOTOX injections in participants with moderate COPD.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2024-04-24
- Completion
- 2024-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | Subcutaneous |